ASCEND benefits from three advisory boards comprised of recognized leaders in science and medicine. These advisors provide counsel and insight regarding new scientific progress, market opportunities, and the successful development and commercialization of ASCEND's products.
Scientific Advisory Board (Corporate)
- Carl Peck, MD
Professor of Pharmacology and Medicine, Center for Drug Development Science, UCSF Director, FDA's Center for Drug Evaluation and Research (1987-1993) - Adrian Dobs, MD, MHS
Professor of Medicine, Division of Endocrinology and Metabolism, Vice Chair for Clinical Research, Johns Hopkins University - Rogerio Lobo, MD
Rappley Professor of OB/GYN, Columbia Presbyterian Hospital, Columbia University - Robert Mansel, MS, FRCS
Chairman of the Division of Surgery, University of Wales - Russell Potts, PhD
Former Vice President, R&D, Cygnus, Inc. (Nicotrol®) - Ronald Swerdloff, MD
Professor of Medicine, Chief, Division of Endocrinology, Department of Medicine, UCLA
National Advisory Board On Cyclic Breast Pain and Afimoxifene Gel
- Robert Mansel, MS, FRCS (Chair)
Chairman of the Division of Surgery, University of Wales - Maura Dickler, MD
Memorial Sloan-Kettering Cancer Center, New York, NY - David Grimes, MD
Family Health International, Research Triangle Park, NC - Seema Khan, MD
Northwestern University, Chicago, IL - Terry Mamounas, MD
Chairman, Breast Committee of the NBABSP Trial Altman Health Foundation, Chicago, IL - Anita Nelson, MD
David Geffen School of Medicine, Torrance, CA - Lisa Rarick, MD
Former Head, FDA, Reproductive and Urology Division - Richard Santen, MD
University of Virginia, Charlottesville, VA - Robin Smith, MD
Mayo Clinic, Rochester, MN
Regulatory Advisory Board
- Carl Peck, MD
Professor of Pharmacology and Medicine, Center for Drug Development Science, UCSF Director, FDA's Center for Drug Evaluation and Research (1987-1993) - Lisa Rarick, MD
Former Head, FDA, Reproductive and Urology Division - Howard Lee, MD, PhD
Assistant Professor, BioPharmaceutical Sciences, Center for Drug Development Science, UCSF - Charles Grudzinkas, PhD
Consultant to the Center for Drug Development Science, UCSF